CY1117722T1 - Βελτιωμενη αγωγη του πολλαπλου μυελωματος - Google Patents
Βελτιωμενη αγωγη του πολλαπλου μυελωματοςInfo
- Publication number
- CY1117722T1 CY1117722T1 CY20161100620T CY161100620T CY1117722T1 CY 1117722 T1 CY1117722 T1 CY 1117722T1 CY 20161100620 T CY20161100620 T CY 20161100620T CY 161100620 T CY161100620 T CY 161100620T CY 1117722 T1 CY1117722 T1 CY 1117722T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cancer
- multiple myeloma
- combinations
- treatment
- improved education
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Η παρούσα εφεύρεση σχετίζεται με συνδυασμούς απλιδίνης ή αναλόγων απλιδίνης με άλλους αντι-ογκικούς παράγοντες, και με την χρήση αυτών των συνδυασμών στην αγωγή του καρκίνου, ειδικότερα στην αγωγή του καρκίνου των πνευμόνων, του καρκίνου του μαστού, του καρκίνου του κόλου, του καρκίνου του προστάτη, του νεφρικού καρκίνου, του μελανώματος, του πολλαπλού μυελώματος, της λευχαιμίας και του λεμφώματος.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81360606P | 2006-02-28 | 2006-02-28 | |
PCT/US2007/062936 WO2007101235A2 (en) | 2006-02-28 | 2007-02-28 | Improved antitumoral treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117722T1 true CY1117722T1 (el) | 2017-05-17 |
Family
ID=38459806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100620T CY1117722T1 (el) | 2006-02-28 | 2016-07-05 | Βελτιωμενη αγωγη του πολλαπλου μυελωματος |
Country Status (24)
Country | Link |
---|---|
US (1) | US8258098B2 (el) |
EP (1) | EP2029155B1 (el) |
JP (2) | JP5393159B2 (el) |
KR (2) | KR101512503B1 (el) |
CN (1) | CN101389347B (el) |
AU (1) | AU2007220050B2 (el) |
CA (1) | CA2643238C (el) |
CY (1) | CY1117722T1 (el) |
DK (1) | DK2029155T3 (el) |
ES (1) | ES2575518T3 (el) |
HK (1) | HK1127294A1 (el) |
HR (1) | HRP20160646T1 (el) |
HU (1) | HUE028055T2 (el) |
IL (1) | IL193094A (el) |
ME (1) | ME02450B (el) |
MX (1) | MX2008010999A (el) |
NO (1) | NO342012B1 (el) |
NZ (1) | NZ571043A (el) |
PL (1) | PL2029155T3 (el) |
PT (1) | PT2029155E (el) |
RS (1) | RS54928B1 (el) |
RU (1) | RU2481853C2 (el) |
SI (1) | SI2029155T1 (el) |
WO (1) | WO2007101235A2 (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE363910T1 (de) * | 1999-11-15 | 2007-06-15 | Pharma Mar Sa | Behandlung von krebserkrankungen durch aplidin |
ES2575518T3 (es) | 2006-02-28 | 2016-06-29 | Pharma Mar S.A. | Tratamiento mejorado de mieloma múltiple |
WO2008135793A1 (en) * | 2007-05-04 | 2008-11-13 | Pharma Mar S.A. | Combination of aplidine and carboplatin in anticancer treatments |
AU2008313627A1 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
RU2010140890A (ru) * | 2008-03-07 | 2012-04-20 | Фарма Мар, С.А. (Es) | Улучшенные способы противоопухолевого лечения |
CN101965191A (zh) * | 2008-03-07 | 2011-02-02 | 法马马有限公司 | 改善的抗癌治疗 |
MX337566B (es) * | 2010-01-05 | 2016-03-10 | Celgene Corp | Combinación de un compuesto inmunomodulador y una artemisinina o un derivado de ésta para tratar cáncer. |
BR122017028570B1 (pt) * | 2010-11-12 | 2022-03-03 | Pharma Mar, S.A | Uso de pm01183, ou um sal farmaceuticamente aceitável do mesmo, em combinação sinérgica com um inibidor da topoisomerase i e/ou ii e kit |
WO2012075211A2 (en) * | 2010-12-01 | 2012-06-07 | Niiki Pharma Inc. | Combination therapy with a gallium complex |
LT2776032T (lt) * | 2011-11-09 | 2018-12-10 | Bristol-Myers Squibb Company | Hematologinių piktybinių navikų gydymas anti-cxcr4 antikūnu |
KR101369936B1 (ko) * | 2011-12-28 | 2014-03-06 | 연세대학교 산학협력단 | 탈리도마이드를 포함하는 루프스 신염 치료용 약학 조성물 |
RU2547999C1 (ru) * | 2013-10-28 | 2015-04-10 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ лечения аденогенного местно-распространенного рака нижнеампулярного отдела прямой кишки |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
US20220026432A1 (en) * | 2018-12-14 | 2022-01-27 | Konica Minolta, Inc. | Method for forecasting arrival of drug inside diseased tissue |
CN113018415B (zh) * | 2021-03-17 | 2022-07-01 | 遵义医科大学 | 一种药物组合及其应用 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4493796A (en) * | 1980-09-12 | 1985-01-15 | Board Of Trustees, Univ. Of Ill. | Didemnins A, B, C, and derivatives thereof, as antiviral agents |
US4950649A (en) * | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
ATE74761T1 (de) * | 1985-09-20 | 1992-05-15 | Cernitin Sa | Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung. |
US4948791A (en) | 1989-04-10 | 1990-08-14 | The Board Of Trustees Of The University Of Illinois | Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
GB8922026D0 (en) | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
US20030148933A1 (en) * | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
DE4120327A1 (de) | 1991-06-20 | 1992-12-24 | Basf Ag | Neue peptide, ihre herstellung und verwendung |
US5580871A (en) * | 1992-11-20 | 1996-12-03 | The Dupont Merck Pharmaceutical Company | 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity |
US5462726A (en) * | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
US6156724A (en) * | 1996-06-07 | 2000-12-05 | Rinehart; Kenneth L. | Uses of didemnins as immunomodulating agents |
JP2001503746A (ja) | 1996-10-24 | 2001-03-21 | ザ・ボード・オブ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・イリノイ | ジデムニン類似体の半合成法 |
DE69723728T2 (de) | 1996-10-24 | 2004-06-03 | The Board Of Trustees For The University Of Illinois, Urbana | Totalsynthese des amino hip analogen von didemnin a |
US6034058A (en) * | 1997-04-15 | 2000-03-07 | Rinehart; Kenneth L. | Semi-synthetic alanyl dilemnin analogs |
DE69840497D1 (de) * | 1997-05-07 | 2009-03-12 | William J Crumb | Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen |
GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
GB9821975D0 (en) | 1998-10-08 | 1998-12-02 | Pharma Mar Sa | New cytotoxic alkaloids |
US6245759B1 (en) * | 1999-03-11 | 2001-06-12 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
RU2266734C2 (ru) * | 1999-05-13 | 2005-12-27 | Фарма Мар, С.А. | Композиции и применение ет743 для лечения злокачественных опухолей |
US6635677B2 (en) * | 1999-08-13 | 2003-10-21 | Case Western Reserve University | Methoxyamine combinations in the treatment of cancer |
ATE363910T1 (de) * | 1999-11-15 | 2007-06-15 | Pharma Mar Sa | Behandlung von krebserkrankungen durch aplidin |
WO2001076616A1 (en) * | 2000-04-07 | 2001-10-18 | The Trustees Of The University Of Pennsylvania | Tamandarin and didemnin analogs and methods of making and using them |
US6509315B1 (en) * | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
UA76718C2 (uk) * | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
AU9402401A (en) * | 2000-10-12 | 2002-04-22 | Pharma Mar Sa | Treatment of cancers |
BR0114604A (pt) * | 2000-10-12 | 2003-10-14 | Pharma Mar Sa | Tratamento de cnceres |
CA2435418A1 (en) | 2001-01-24 | 2002-08-01 | Mestex Ag | Use of neurotoxic substances in producing a medicament for treating joint pains |
PT1435991E (pt) | 2001-10-19 | 2009-01-16 | Pharma Mar Sa | Utilização de aplidina para o tratamento de cancro pancreático |
AU2004218883B2 (en) * | 2003-03-12 | 2009-10-01 | Dana-Farber Cancer Institute, Inc. | Aplidine for multiple myeloma treatment |
KR20060002778A (ko) * | 2003-03-12 | 2006-01-09 | 파르마 마르, 에스.에이. | 개선된 항종양 치료 |
WO2004084812A2 (en) | 2003-03-21 | 2004-10-07 | Joullie Madeleine M | Tamandarin analogs and fragments thereof and methods of making and using |
JP2007516693A (ja) * | 2003-06-09 | 2007-06-28 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | 癌の治療および診断のための組成物および方法 |
ES2575518T3 (es) | 2006-02-28 | 2016-06-29 | Pharma Mar S.A. | Tratamiento mejorado de mieloma múltiple |
DE102006061344A1 (de) * | 2006-12-22 | 2008-06-26 | Robert Bosch Gmbh | Kupplungshydraulikkreis |
WO2008080956A1 (en) | 2006-12-29 | 2008-07-10 | Pharma Mar, S.A. | Prognostic molecular markers for the cancer therapy with aplidine |
WO2008135793A1 (en) | 2007-05-04 | 2008-11-13 | Pharma Mar S.A. | Combination of aplidine and carboplatin in anticancer treatments |
AU2008313627A1 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
WO2010029158A1 (en) | 2008-09-12 | 2010-03-18 | Pharma Mar, S.A. | Aplidine in the treatment of chronic myeloproliferative disorders |
-
2007
- 2007-02-28 ES ES07757603.1T patent/ES2575518T3/es active Active
- 2007-02-28 RU RU2008138560/15A patent/RU2481853C2/ru active
- 2007-02-28 WO PCT/US2007/062936 patent/WO2007101235A2/en active Application Filing
- 2007-02-28 PL PL07757603.1T patent/PL2029155T3/pl unknown
- 2007-02-28 DK DK07757603.1T patent/DK2029155T3/en active
- 2007-02-28 EP EP07757603.1A patent/EP2029155B1/en active Active
- 2007-02-28 PT PT07757603T patent/PT2029155E/pt unknown
- 2007-02-28 ME MEP-2016-115A patent/ME02450B/me unknown
- 2007-02-28 CN CN2007800068661A patent/CN101389347B/zh active Active
- 2007-02-28 KR KR1020087023662A patent/KR101512503B1/ko active IP Right Grant
- 2007-02-28 MX MX2008010999A patent/MX2008010999A/es active IP Right Grant
- 2007-02-28 JP JP2008557477A patent/JP5393159B2/ja active Active
- 2007-02-28 NZ NZ571043A patent/NZ571043A/en unknown
- 2007-02-28 RS RS20160545A patent/RS54928B1/sr unknown
- 2007-02-28 SI SI200731777A patent/SI2029155T1/sl unknown
- 2007-02-28 HU HUE07757603A patent/HUE028055T2/en unknown
- 2007-02-28 CA CA2643238A patent/CA2643238C/en active Active
- 2007-02-28 AU AU2007220050A patent/AU2007220050B2/en active Active
- 2007-02-28 KR KR1020147021341A patent/KR20140101014A/ko not_active Application Discontinuation
- 2007-02-28 US US12/278,559 patent/US8258098B2/en active Active
-
2008
- 2008-07-28 IL IL193094A patent/IL193094A/en active IP Right Grant
- 2008-09-23 NO NO20084047A patent/NO342012B1/no unknown
-
2009
- 2009-07-16 HK HK09106467.2A patent/HK1127294A1/zh unknown
-
2013
- 2013-07-10 JP JP2013144436A patent/JP2013199500A/ja active Pending
-
2016
- 2016-06-10 HR HRP20160646TT patent/HRP20160646T1/hr unknown
- 2016-07-05 CY CY20161100620T patent/CY1117722T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1117722T1 (el) | Βελτιωμενη αγωγη του πολλαπλου μυελωματος | |
CY1113637T1 (el) | Ενωση αμινο πυραζολης | |
CY1123660T1 (el) | Ενωσεις 1-τετραϋδροπυρανυλοκαρβονυλο-2,3-διυδρο-1η-ινδολιου για την αγωγη του καρκινου | |
CY1119030T1 (el) | Χρηση των δεσμων σιγμα στον πονο του καρκινου των οστων | |
EA201171367A1 (ru) | Винилиндазолильные соединения | |
EP2569434A4 (en) | COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA | |
EA201300242A1 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
EA201890158A1 (ru) | Антитела против ntb-a и связанные композиции и способы | |
MY160736A (en) | Bivalent, bispecific antibodies | |
MX354099B (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
EA200970987A1 (ru) | Трициклические азотсодержащие соединения в качестве антибактериальных агентов | |
EA201070179A1 (ru) | Антиген, связанный с вариантами рака легкого и лимфомами | |
TN2017000486A1 (en) | Polycyclic amide derivatives as cdk9 inhibitors | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
MX342250B (es) | Tratamiento de cánceres resistentes a antagonistas notch1, mediante el uso de antagonistas notch3. | |
CY1119890T1 (el) | Θεραπευτικη αγωγη ογκων χρησιμοποιωντας ειδικο αντισωμα αντι-l1 | |
EA201270606A1 (ru) | Новое противоопухолевое применение кабазитаксела | |
FR2945210B1 (fr) | Combinaison antitumorale comprenant l'ave8062 et le sorafenib | |
TR201909522T4 (tr) | Anti-tümör aktivitesine sahip bir nonapeptit. | |
EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
EA200971103A1 (ru) | Иммуноцитокины для лечения рака в сочетании с химиотерапевтическими агентами | |
ATE533861T1 (de) | Mipol1-etv1-gen-neuanordnungen | |
NZ593169A (en) | Anticancer compounds | |
UA128071U (uk) | Етил-2-(хіназолін-4-іл-аміно)-4,5,6,7-тетрагідро-1-бензотіофен-3-карбоксилат гідрохлорид, що має протипухлинну активність при недрібноклітинному раку легенів людини | |
CL2020002475S1 (es) | Medidor eléctrico. |